Cover Image
Market Research Report

Global Nanobiotechnology Market 2018-2022

Published by TechNavio (Infiniti Research Ltd.) Product code 657666
Published Content info 113 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Nanobiotechnology Market 2018-2022
Published: June 27, 2018 Content info: 113 Pages
Description

About Nanobiotechnology

Nanobiotechnology is a discipline in which tools from nanobiotechnology are developed and applied to study biological phenomena.

Technavio's analysts forecast the Global Nanobiotechnology Market to grow at a CAGR of 8.51% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global nanobiotechnology market. To calculate the market size, the report considers the revenue generated from the sales of nanobiotechnology products such as nanoparticles, bionanomaterials, and liposomes.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Nanobiotechnology Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Ablynx
  • CELGENE
  • Merck KGaA
  • NanoBiotech Pharma
  • Thermo Fisher Scientific

Market driver

  • Increasing focus on nanotechnology research
  • For a full, detailed list, view our report

Market challenge

  • Lack of trained professionals
  • For a full, detailed list, view our report

Market trend

  • High prevalence of chronic diseases
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR22571

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY END-USER

  • Segmentation by end-user
  • Comparison by end-user
  • Pharmaceutical and biotechnology industry- Market size and forecast 2017-2022
  • Medical devices - Market size and forecast 2017-2022
  • Others - Market size and forecast 2017-2022
  • Market opportunity by end-user

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increasing demand for nanobiotechnology in stem cell therapy
  • High prevalence of chronic diseases
  • Growing use of gold nanoparticles

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Ablynx
  • CELGENE
  • Merck KGaA
  • NanoBiotech Pharma
  • Thermo Fisher Scientific

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global nanotechnology market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global nanobiotechnology market- Market size and forecast 2017-2022 ($ bn)
  • Exhibit 09: Global nanobiotechnology market- Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global nanobiotechnology market by end-user - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Pharmaceutical and biotechnology industry - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 21: Pharmaceutical and biotechnology industry - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: Medical devices- Market size and forecast 2017-2022 ($ bn)
  • Exhibit 23: Medical devices- Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Others - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 25: Others - Year-over-year growth 2018-2022 (%)
  • Exhibit 26: Market opportunity by end-user
  • Exhibit 27: Customer landscape
  • Exhibit 28: Global nanobiotechnology market - Market share by geography 2017-2022 (%)
  • Exhibit 29: Regional comparison
  • Exhibit 30: Americas - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 31: Americas - Year over year growth 2018-2022 (%)
  • Exhibit 32: Top three countries in Americas
  • Exhibit 33: EMEA - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 34: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 35: Top three countries in EMEA
  • Exhibit 36: APAC - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 37: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 38: Top 3 countries in APAC
  • Exhibit 39: Market opportunity
  • Exhibit 40: Nanobiotechnology-based products under clinical trials
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Ablynx overview
  • Exhibit 47: Ablynx - Business segments
  • Exhibit 48: Ablynx - Organizational developments
  • Exhibit 49: Ablynx - Geographic focus
  • Exhibit 50: Ablynx - Segment focus
  • Exhibit 51: Ablynx - Key offerings
  • Exhibit 52: CELGENE overview
  • Exhibit 53: CELGENE - Business segments
  • Exhibit 54: CELGENE - Organizational developments
  • Exhibit 55: CELGENE - Geographic focus
  • Exhibit 56: CELGENE - Segment focus
  • Exhibit 57: CELGENE - Key offerings
  • Exhibit 58: Merck KGaA overview
  • Exhibit 59: Merck KGaA - Business segments
  • Exhibit 60: Merck KGaA - Organizational developments
  • Exhibit 61: Merck KGaA - Geographic focus
  • Exhibit 62: Merck KGaA - Segment focus
  • Exhibit 63: Merck KGaA - Key offerings
  • Exhibit 64: NanoBiotech Pharma overview
  • Exhibit 65: NanoBiotech Pharma - Business segments
  • Exhibit 66: NanoBiotech Pharma - Organizational developments
  • Exhibit 67: NanoBiotech Pharma - Geographic focus
  • Exhibit 68: NanoBiotech pharma - Key offerings
  • Exhibit 69: Thermo Fisher Scientific overview
  • Exhibit 70: Thermo Fisher Scientific - Business segments
  • Exhibit 71: Thermo Fisher Scientific - Organizational developments
  • Exhibit 72: Thermo Fisher Scientific - Geographic focus
  • Exhibit 73: Thermo Fisher Scientific - Segment focus
  • Exhibit 74: Thermo Fisher Scientific - Key offerings
Back to Top